DAXDILIMAB
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for DAXDILIMAB, covering 2025-01-07 to 2026-08-25. Get the full timeline:
Most recent: Clinical Trial Results: A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) [Phase 2]